Endoscopic Submucosal Dissection Market Value to Reach US$ 483 Mn by 2032 Driven by GI Cases

✅Endoscopic Submucosal Dissection Market Overview and Growth Analysis

The endoscopic submucosal dissection (ESD) market is witnessing significant growth, driven by the rising prevalence of gastrointestinal cancers and the increasing demand for minimally invasive procedures. ESD, originally developed in Japan, has gained international acceptance due to its ability to remove superficial neoplasms from the gastrointestinal tract without the need for major surgery. The market was valued at US$ 295 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.4%, reaching US$ 483 million by 2032.

Key growth factors include the growing elderly population, advancements in endoscopic imaging technologies, and increasing awareness of early cancer detection. Among the segments, gastrointestinal ESD procedures dominate due to the high prevalence of colorectal and gastric cancers. Geographically, Asia Pacific leads the market, especially Japan and South Korea, where early cancer screening and adoption of advanced endoscopic techniques are standard clinical practice. North America is also growing swiftly, driven by rising healthcare expenditure and growing procedural awareness among patients.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/22897

✅Key Highlights from the Report

➤The market is forecast to reach US$ 483 million by 2032, growing at a 7.4% CAGR
➤Asia Pacific leads the market due to advanced healthcare systems and early adoption
➤Gastrointestinal ESD dominates the application segment globally
➤Hospitals remain the primary end-user, followed by specialized endoscopy clinics
➤Technological innovation in ESD knives and electrosurgical units boosts market adoption
➤Aging population and higher cancer screening rates are critical demand drivers

✅What is Endoscopic Submucosal Dissection Used For?

What are the primary applications of endoscopic submucosal dissection (ESD) procedures?

Endoscopic submucosal dissection is primarily used to remove early-stage cancerous or precancerous lesions from the gastrointestinal tract without the need for open surgery. The procedure enables en bloc resection, which means the entire lesion is removed in one piece. This is especially valuable in treating cancers of the esophagus, stomach, colon. ESD is particularly advantageous because it reduces the recurrence rate of tumors and allows precise histological examination of the resected specimen.

Additionally, ESD is used in managing complex polyps that cannot be removed using conventional endoscopic mucosal resection (EMR). It offers a safer and more effective alternative to surgical resection, especially in high-risk or elderly patients. Over time, the scope of ESD has expanded beyond oncological use to include benign tumors and severe dysplasias. Due to its high efficacy, improved patient recovery, and reduced hospital stays, ESD continues to gain traction among gastroenterologists and healthcare facilities worldwide.

✅Market Segmentation

The endoscopic submucosal dissection market is segmented based on product type, which includes ESD knives, injection agents, electrosurgical generators, hemostatic devices, and other accessories. Among these, ESD knives hold the dominant market share due to their pivotal role in tissue resection. Electrosurgical generators are also essential, enabling precise energy delivery during dissection procedures. Ongoing advancements in ESD knife design and electrical safety are improving procedural outcomes.

In terms of end users, the market is primarily segmented into hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals lead due to their comprehensive infrastructure, access to trained endoscopists, and availability of advanced surgical tools. However, ASCs are rapidly emerging as key service providers owing to cost-effective treatment delivery and shorter patient recovery times, particularly in developed regions such as North America and Europe.

✅Regional Insights

The Asia Pacific region, especially Japan, South Korea, and China, dominates the ESD market due to widespread screening programs and early adoption of advanced endoscopic procedures. Japan, where ESD was first introduced, continues to lead in clinical training, research, and product development. Public awareness and government health initiatives also support this regional dominance.

In North America and Europe, the market is experiencing steady growth. The increasing burden of colorectal cancer and rising healthcare investments are key growth enablers. Favorable reimbursement scenarios, coupled with a growing pool of trained gastroenterologists, are helping to bridge the gap between availability and accessibility in these regions.

✅Market Drivers

The global burden of gastrointestinal cancers is escalating, prompting the need for early detection and minimally invasive treatment techniques. ESD offers superior outcomes over traditional surgical procedures, significantly reducing patient morbidity and hospital stays. Additionally, increasing healthcare expenditure and awareness about gastrointestinal disorders are driving higher adoption rates of ESD in both developed and developing nations.

✅Market Restraints

Despite its clinical advantages, ESD remains a technically challenging procedure that requires significant expertise and training. Limited availability of skilled professionals, particularly in developing countries, hampers widespread adoption. Furthermore, the high cost of ESD equipment and procedural tools poses a barrier for small healthcare facilities and budget-constrained public hospitals.

✅Market Opportunities

The increasing acceptance of outpatient endoscopic procedures and the emergence of AI-based navigation systems are creating new avenues for market growth. Moreover, partnerships between device manufacturers and hospitals for training programs are expected to alleviate the skill gap. Innovations in disposable ESD tools and real-time imaging could also lower procedural risks and improve outcomes, making ESD more accessible and effective.

✅Reasons to Buy the Report

☑Comprehensive analysis of current market dynamics and future growth projections
☑Detailed segmentation based on product type and end-user landscape
☑Regional insights highlighting leading markets and emerging economies
☑Profiles and strategies of leading market players with latest updates
☑Valuable data on market challenges, opportunities, and technological advancements

✅Company Insights

✦Olympus Corporation
✦Boston Scientific Corporation
✦FUJIFILM Holdings Corporation
✦ERBE Elektromedizin GmbH
✦Medtronic plc
✦Pentax Medical (HOYA Group)
✦ConMed Corporation
✦Zeon Medical Inc.
✦MTW Endoskopie W. Haag KG
✦Micro-Tech Endoscopy

■In 2024, Olympus introduced a new-generation ESD knife featuring enhanced precision and safety features aimed at reducing procedural time.

■Boston Scientific expanded its endoscopy portfolio through a strategic acquisition of a start-up specializing in AI-guided therapeutic endoscopy tools in early 2025.

✅Conclusion

The endoscopic submucosal dissection market is on a robust growth trajectory, driven by rising cancer incidence, increasing preference for minimally invasive treatments, and expanding global awareness of early disease management. With continued innovation in ESD tools and procedural techniques, along with supportive healthcare policies in key regions, the market is set to achieve substantial growth over the coming years. Companies investing in training, product development, and regional expansion stand to gain the most as demand for precise and effective endoscopic treatments continues to surge.

✅About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.